OCAN to Join Others on Capitol Hill
On September 26 and 27, leaders from the Obesity Care Advocacy Network (OCAN) will join with over 400 employees of Novo Nordisk, Inc, for a two-day advocacy blitz of Capitol Hill to urge Congress to pass S. 830/H.R. 1953- the Treat and Reduce Obesity Act (TROA). The legislation, which has the bipartisan support of over 100 House and Senate co-sponsors, aims to effectively treat and reduce obesity in older Americans by enhancing Medicare beneficiaries’ access to healthcare providers that are best suited to provide intensive behavioral therapy (IBT) and by allowing Medicare Part D to cover FDA-approved obesity drugs.
The upcoming September advocacy days will build on more than 250 OCAN congressional visits this year to grow support for TROA, which continues to be championed by Senators Bill Cassidy (R-LA) and Tom Carper (D-DE) and Representatives Erik Paulsen (R-MN) and Ron Kind (D-WI). This time around, advocates will be armed with a new analysis that highlights how passage of TROA could save the Medicare program between $19-21 billion during the next 10 years.